The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
A bipartisan group of state health policymakers from both the executive and legislative branches who are focused on improving population health.
Supporting networks of state officials, advocates, and others aiming to invest in and transform primary care.
Advancing state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
A leadership development program for early and mid-career state government officials who are committed to improving the health of all people in their communities.
A leadership program for senior state government officials who are committed to improving population health.
The Fund focuses on creating an affordable health care system built on strong primary care and partnerships that improve health outcomes for all.
Improving state leaders ability to enact and implement evidence-based health policies.
Advancing policies that create a more prevention- and primary care-oriented health system.
Improving population health through policies that contain health care cost growth.
Our state health policy resources provide relevant data analysis and best practices.
The Fund publishes reports, issues briefs, and case studies on state health policy issues.
Short takes on health policy issues from Milbank staff and guest authors.
Insights from Milbank President Debra Lubar on state health policymaking.
Reported articles and Q&As on timely health policy issues, as well as foundation updates.
Upcoming and past Milbank Memorial Fund and Milbank Quarterly webinars featuring state health policymakers and researchers.
Updates and expert contact information for reporters.
The Milbank Memorial Fund is a private foundation that works to improve population health and health equity.
The Future of Population Health (Volume 101)
Quarterly Article
Kushal T. Kadakia
Anaeze C. Offodile
Kadakia KT, Offodile AC. The Next Generation of Payment Reforms for Population Health – An Actionable Agenda for 2035 Informed by Past Gains and Ongoing Lessons. Milbank Q. 2023;101(S1): 866-892.
Sep 2, 2026
December 2025
September 2024
Back to The Milbank Quarterly
Policy Points:
The American paradox of spending a disproportionately greater share of the country’s gross domestic product on health care without achieving commensurate improvements in care quality or outcomes has long rendered the United States an outlier in comparison to other high-income countries.1 Although the economic shock of the COVID-19 pandemic induced a temporary deceleration in spending growth, national health expenditures in the United States still exceeded $4.3 trillion in 2021, and are projected by the Centers for Medicare & Medicaid Services (CMS) to reach $6.3 trillion by 2030.2 Other countries around the world are also grappling with the challenge of curtailing spending, which in both the United States and abroad can be attributed to a number of factors including the evolving burden of chronic diseases, the aging population, and the cost of new medical technologies. However, US health care spending remains aberrant even after accounting for these factors, from substantial added costs arising from administrative waste and unnecessary service provision to fragmented care and incentive misalignment.3
These excess expenditures also reflect a fundamental flaw in how resources are allocated across the American health care system. For example, the United States spends three times as much on wasteful administrative complexity as it does on the entirety of federal, state, and local public health.4 Likewise, the literature on low-value care—which accounts for nearly $100 billion in wasteful spending—should be considered alongside emerging evidence about the under-provision of high-value care, with many high-risk patients often lacking access to clinically appropriate diagnostics and therapeutics.5 Resource misallocation not only exacerbates financial strain for payers, employers, and families, but also contributes to longstanding inequities in health care organization and delivery exemplified by worse access and outcomes for racial and ethnic minorities and low-income populations.6,7
To address these challenges, US health care reform over the past decade has placed substantial focus on rewiring health care financing, specifically increasing provider accountability for utilization (i.e., cost) and/or outcomes. Previous legislation and administrative action sought to slow spending by regulating either the quantity (e.g., the so-called “managed care revolution” of the 1990s) or the price (e.g., Medicare’s Sustainable Growth Rate, which was repealed in 2015) of health care services.8 However, these approaches often focused disproportionately on moderating costs over improving outcomes, and also lacked the broad stakeholder support that is necessary to achieve durable change. Instead, with the passage of the Affordable Care Act (ACA) in 2010, lawmakers sought to promote policies focused on marrying the goals of payment reforms (lower costs) and delivery system transformation (better quality and outcomes).